Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | 126,479 | reported | 15 May 2026 | tx 154+1,446,782−643,824 |
| NEUROCRINE BIOSCIENCES INC | 2,567 | reported | 27 May 2026 | tx 15+59,282−6,853 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | NEUROCRINE BIOSCIENCES INC | 2,567 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | |
| 21 May 2026 | EXERCISE | NEUROCRINE BIOSCIENCES INC | 3,318 | 0.00 USD | deriv |
| 15 May 2026 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 66.64 USD | 10b5-1 |
| 15 May 2026 | SALE | GILEAD SCIENCES, INC. | 7,749 | 130.29 USD | 10b5-1 |
| 15 May 2026 | SALE | GILEAD SCIENCES, INC. | 11,177 | 131.19 USD | 10b5-1 |
| 15 May 2026 | SALE | GILEAD SCIENCES, INC. | 8,374 | 132.23 USD | 10b5-1 |
| 15 May 2026 | SALE | GILEAD SCIENCES, INC. | 700 | 132.75 USD | 10b5-1 |
| 15 May 2026 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 0.00 USD | 10b5-1deriv |
| 16 Mar 2026 | SALE | GILEAD SCIENCES, INC. | 3,000 | 144.23 USD | |
| 10 Mar 2026 | EXERCISE | GILEAD SCIENCES, INC. | 6,617 | — | |
| 10 Mar 2026 | TAX_WITHHOLDING | GILEAD SCIENCES, INC. | 3,216 | 148.56 USD | |
| 10 Mar 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 9,590 | — | deriv |
| 10 Mar 2026 | EXERCISE | GILEAD SCIENCES, INC. | 6,617 | — | deriv |
| 10 Mar 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 35,880 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 11,090 | 0.00 USD | |
| 17 Feb 2026 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 66.64 USD | |
| 17 Feb 2026 | SALE | GILEAD SCIENCES, INC. | 18,405 | 154.18 USD | |
| 17 Feb 2026 | SALE | GILEAD SCIENCES, INC. | 9,395 | 154.91 USD | |
| 17 Feb 2026 | SALE | GILEAD SCIENCES, INC. | 200 | 155.62 USD | |
| 17 Feb 2026 | EXERCISE | GILEAD SCIENCES, INC. | 25,000 | 0.00 USD | deriv |
| 03 Feb 2026 | TAX_WITHHOLDING | GILEAD SCIENCES, INC. | 24,800 | 143.28 USD | |
| 03 Feb 2026 | GRANT_AWARD | GILEAD SCIENCES, INC. | 44,867 | 0.00 USD | |
| 15 Jan 2026 | SALE | GILEAD SCIENCES, INC. | 3,000 | 124.31 USD | |
| 15 Dec 2025 | SALE | GILEAD SCIENCES, INC. | 3,000 | 122.00 USD |